The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study
Open accessAbstract
Background: The natural history of hepatitis C virus (HCV) infection remains uncertain. Previous data concerning rates of progression are from studies using estimated dates of infection and single liver biopsy scores. We prospectively studied the rate of progression of fibrosis in HCV infected patients by repeat liver biopsies without intervening treatment. Patients: We studied 214 HCV infected patients (126 male; median age 36 years (range 5–8)) with predominantly mild liver disease who were prospectively followed without treatment and assessed for risk factors for progression of liver disease. Interbiopsy interval was a median of 2.5 years. Paired biopsies from the same patient were scored by the same pathologist. Results: Seventy of 219 (33%) patients showed progression of at least 1 fibrosis point in the Ishak score; 23 progressed at least 2 points. Independent predictors of progression were age at first biopsy and any fibrosis on first biopsy. Factors not associated with progression were: necroinflammation, duration of infection, alcohol consumption, alanine aminotransferase levels, current or past hepatitis B virus infection, ferritin, HCV genotype, and steatosis or iron deposition in the initial biopsy. Conclusions: One third of patients with predominantly mild hepatitis C showed significant fibrosis progression over a median period of 30 months. Histologically, mild hepatitis C is a progressive disease. The overall rate of fibrosis progression in patients with hepatitis C was low but increased in patients who were older or had fibrosis on their index biopsy. These data suggest that HCV infection will place an increasing burden on health care services in the next 20 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
Histological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029
Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., & Wollman, J. (1981) · Hepatology · doi:10.1002/hep.1840010511 · Cited by 3,522
McHutchison, J. G., Gordon, S. C., Schiff, E. R., Shiffman, M. L., Lee, W. M., Rustgi, V. K., Goodman, Z. D., Ling, M.-H., Cort, S., & Albrecht, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811193392101 · Cited by 3,465
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
Poynard, T., Marcellin, P., Lee, S. S., Niederau, C., Minuk, G. S., Ideo, G., Bain, V., Heathcote, J., Zeuzem, S., Trepo, C., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)07124-4 · Cited by 2,318
Clinical Outcomes after Hepatitis C Infection from Contaminated Anti-D Immune Globulin
Kenny-Walsh, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401602 · Cited by 910
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c
Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00097-0 · Cited by 749
Fibrosis in Chronic Hepatitis C Correlates Significantly With Body Mass Index and Steatosis
Hourigan, L. F., Macdonald, G. A., Purdie, D., Whitehall, V. H., Shorthouse, C., Clouston, A., & Powell, E. E. (1999) · Hepatology · doi:10.1002/hep.510290401 · Cited by 674
Occult Hepatitis B Virus Infection in Patients with Chronic Hepatitis C Liver Disease
Cacciola, I., Pollicino, T., Squadrito, G., Cerenzia, G., Orlando, M. E., & Raimondo, G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907013410104 · Cited by 666
Berenguer, M., Prieto, M., Juan, F. S., Rayón, J. M., Martinez, F., Carrasco, D., Moya, A., Orbis, F., Mir, J., & Berenguer, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33993 · Cited by 599
The Long–Term Pathological Evolution of Chronic Hepatitis C
Yano, M., Kumada, H., Kage, M., Ikeda, K., Shimamatsu, K., Inoue, O., Hashimoto, E., Lefkowitch, J. H., Ludwig, J., & Okuda, K. (1996) · Hepatology · doi:10.1002/hep.510230607 · Cited by 598
Dusheiko, G., Schmilovitz-Weiss, H., Brown, D., McOmish, F., Yap, P.-L., Sherlock, S., McIntyre, N., & Simmonds, P. (1994) · Hepatology · doi:10.1002/hep.1840190104 · Cited by 561
McOmish, F., Yap, P. L., Dow, B. C., Follett, E. A., Seed, C., Keller, A. J., Cobain, T. J., Krusius, T., Kolho, E., & Naukkarinen, R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.4.884-892.1994 · Cited by 509
Progression of fibrosis in chronic hepatitis C
Ghany, M. G., Kleiner, D. E., Alter, H., Doo, E., Khokar, F., Promrat, K., Herion, D., Park, Y., Liang, T. J., & Hoofnagle, J. H. (2003) · Gastroenterology · doi:10.1053/gast.2003.50018 · Cited by 403
Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C
Hickman, I. J., Clouston, A. D., Macdonald, G. A., Purdie, D. M., Prins, J. B., Ash, S., Jonsson, J. R., & Powell, E. E. (2002) · Gut · doi:10.1136/gut.51.1.89 · Cited by 302
Roudot-Thoraval, F., Bastie, A., Pawlotsky, J., & Dhumeaux, D. (1997) · Hepatology · doi:10.1002/hep.510260233 · Cited by 297
Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C
Wali, M., Harrison, R. F., Gow, P. J., & Mutimer, D. (2002) · Gut · doi:10.1136/gut.51.2.248 · Cited by 274
Silini, E., Bono, F., Cividini, A., Cerino, A., Bruno, S., Rossi, S., Belloni, G., Brugnetti, B., Civardi, E., Salvaneschi, L., et al. (1995) · Hepatology · doi:10.1002/hep.1840210204 · Cited by 252
Weltman, M. D., Brotodihardjo, A., Crewe, E. B., Farrell, G. C., Bililus, M., Grierson, J. M., & Liddle, C. (1995) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.1995.tb00070.x · Cited by 182
Intra-observer variation in the histopathological assessment of chronic viral hepatitis
Goldin, R. D., Goldin, J. G., Burt, A. D., Dhillon, A. P., Hubscher, S., Wyatt, J. I., & Patel, N. K. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80234-0 · Cited by 153
The epidemiology of hepatitis C in a UK health regional population of 5.12 million
Mohsen, A. H., & Trent HCV Study Group (2001) · Gut · doi:10.1136/gut.48.5.707 · Cited by 112
Steatosis and intrahepatic hepatitis C virus in chronic hepatitis
Fujie, H., Yotsuyanagi, H., Moriya, K., Shintani, Y., Tsutsumi, T., Takayama, T., Makuuchi, M., Matsuura, Y., Miyamura, T., Kimura, S., et al. (1999) · Journal of Medical Virology · Cited by 111
Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C
Beinker, N. K., Voigt, M. D., Arendse, M., Smit, J. L., Stander, I. A., & Kirsch, R. E. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80231-5 · Cited by 93
Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C
Fontaine, H., Nalpas, B., Poulet, B., Carnot, F., Zylberberg, H., Bréchot, C., & Pol, S. (2001) · Human Pathology · doi:10.1053/hupa.2001.28228 · Cited by 92
Pelletier, S. J., Iezzoni, J. C., Crabtree, T. D., Hahn, Y. S., Sawyer, R. G., & Pruett, T. L. (2000) · Liver Transplantation · doi:10.1002/lt.500060111 · Cited by 83
Zignego, A. L., Fontana, R., Puliti, S., Barbagli, S., Monti, M., Careccia, G., Giannelli, F., Giannini, C., Buzzelli, G., Brunetto, M. R., et al. (1997) · PubMed · Cited by 79
Progression of fibrosis in untreated patients with hepatitis C virus infection
Lagging, M., Westin, J., Svensson, E., Aires, N., Dhillon, A. P., Lindh, M., Wejstål, R., & Norkrans, G. (2002) · Liver International · doi:10.1034/j.1600-0676.2002.01623.x · Cited by 77
Liver iron concentration in chronic viral hepatitis: a study of 98 patients
Piperno, A., Alba, R. D., Fargion, S. R., Roffi, L., Sampietro, M., Parma, S., Arosio, V., Far, M., & Fiorelli, G. (1995) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199512000-00014 · Cited by 69
Booth, J., Foster, G. R., Kumar, U., Galassini, R., Goldin, R. D., Brown, J. L., & Thomas, H. C. (1995) · Gut · doi:10.1136/gut.36.3.427 · Cited by 63
Iron, hepatic stellate cells and fibrosis in chronic hepatitis C
Rigamonti, C., Andorno, S., Maduli, E., Morelli, S., Pittau, S., Nicosia, G., Boldorini, R. L., & Sartori, M. G. F. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.0320s1028.x · Cited by 45
Presentation of hepatitis C in a unique uniform cohort 17 years from inoculation
Crowe, S. F., Doyle, C., Fielding, J. F., Holloway, H., Keegan, M., Kelleher, D. P., Kelly, P., Leader, M., Little, M. A., McDonald, G. S. A., et al. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)28518-0 · Cited by 26
Cited by
Benson, A. B., Abrams, T. A., Ben-Josef, E., Bloomston, P. M., Botha, J. F., Clary, B. M., Covey, A., Curley, S. A., D'Angelica, M. I., Davila, R., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0027 · Cited by 2,268
Davis, G. L., Alter, M. J., El–Serag, H., Poynard, T., & Jennings, L. W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.067 · Cited by 878
The Natural History of Hepatitis C Virus (HCV) Infection
Chen, S. L., & Morgan, T. R. (2006) · International Journal of Medical Sciences · doi:10.7150/ijms.3.47 · Cited by 860
Thein, H., Yi, Q., Dore, G. J., & Krahn, M. D. (2008) · Hepatology · doi:10.1002/hep.22375 · Cited by 829
Kim, I. H., Kisseleva, T., & Brenner, D. A. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000176 · Cited by 497
Metadata
- Authors
- Ryder, S. D.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2004-02-11
- Volume
- 53
- Issue
- 3
- Pages
- 451-455
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W1995813950
- Cited by
- 276
- References
- 32
- FWCI
- 16.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.